Tilray Inc (NASDAQ:TLRY) Shares Purchased by State Street Corp

State Street Corp increased its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 4.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,961,338 shares of the company’s stock after buying an additional 88,079 shares during the quarter. State Street Corp’s holdings in Tilray were worth $3,452,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Point72 Asset Management L.P. purchased a new stake in shares of Tilray during the 3rd quarter valued at $1,348,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Tilray by 6.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,677,899 shares of the company’s stock valued at $2,953,000 after acquiring an additional 107,530 shares during the period. CreativeOne Wealth LLC purchased a new stake in shares of Tilray in the third quarter worth about $127,000. BNP Paribas Financial Markets raised its holdings in shares of Tilray by 1,314.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock valued at $3,202,000 after buying an additional 1,690,827 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in Tilray by 4.9% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 715,672 shares of the company’s stock worth $1,260,000 after acquiring an additional 33,194 shares during the period. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Tilray Stock Down 4.9 %

Shares of NASDAQ:TLRY opened at $1.36 on Tuesday. The firm has a market cap of $1.23 billion, a PE ratio of -5.04 and a beta of 2.08. The company has a fifty day simple moving average of $1.42 and a 200 day simple moving average of $1.64. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. Tilray Inc has a 12-month low of $1.14 and a 12-month high of $2.97.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The firm had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. During the same period last year, the business posted ($0.10) earnings per share. The firm’s revenue for the quarter was up 13.0% on a year-over-year basis. On average, equities research analysts anticipate that Tilray Inc will post -0.14 EPS for the current fiscal year.

Insider Transactions at Tilray

In other news, CFO Carl A. Merton bought 26,000 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was purchased at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the transaction, the chief financial officer now owns 26,000 shares in the company, valued at approximately $35,360. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.87% of the company’s stock.

Analysts Set New Price Targets

Separately, Roth Mkm lowered their target price on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.